Advertisement
U.S. markets closed

Verve Therapeutics, Inc. (VERV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
4.8500+0.2500 (+5.43%)
At close: 04:00PM EST
4.8400 -0.01 (-0.21%)
After hours: 07:57PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
24,396
11,758
1,941
0
0
Operating Expense
250,937
234,882
167,628
87,067
40,627
Operating Income
-226,541
-223,124
-165,687
-87,067
-40,627
Net Non Operating Interest Income Expense
28,793
23,166
6,867
142
162
Other Income Expense
1,030
165
1,486
-33,389
-5,239
Pretax Income
-196,718
-199,793
-157,334
-120,314
-45,704
Tax Provision
308
275
53
0
0
Net Income Common Stockholders
-197,026
-200,068
-157,387
-120,314
-45,704
Diluted NI Available to Com Stockholders
-197,026
-200,068
-157,387
-120,314
-45,704
Basic EPS
-3.08
-3.12
-2.91
-4.48
-1.57
Diluted EPS
-3.08
-3.12
-2.91
-4.48
-1.57
Basic Average Shares
62,129
64,175
54,024
26,872
29,174
Diluted Average Shares
63,737
64,175
54,024
26,872
29,174
Total Operating Income as Reported
-226,541
-223,124
-165,687
-87,067
-40,627
Total Expenses
250,937
234,882
167,628
87,067
40,627
Net Income from Continuing & Discontinued Operation
-197,026
-200,068
-157,387
-120,314
-45,704
Normalized Income
-197,026
-200,068
-157,387
-120,314
-45,704
Interest Income
-
-
-
-
162
Net Interest Income
28,793
23,166
6,867
142
162
EBIT
-226,541
-223,124
-165,687
-87,067
-40,627
EBITDA
-219,971
-217,669
-162,883
-85,532
-39,299
Reconciled Depreciation
6,570
5,455
2,804
1,535
1,328
Net Income from Continuing Operation Net Minority Interest
-197,026
-200,068
-157,387
-120,314
-45,704
Normalized EBITDA
-219,971
-217,669
-162,883
-85,532
-39,299
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0